Literature DB >> 9351827

Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment.

R Taneja1, C Rochette-Egly, J L Plassat, L Penna, M P Gaub, P Chambon.   

Abstract

The role of RAR alpha 1 and RAR gamma 2 AF-1 and AF-2 activation functions and of their phosphorylation was investigated during RA-induced primitive and parietal differentiation of F9 cells. We found that: (i) primitive endodermal differentiation requires RAR gamma 2, whereas parietal endodermal differentiation requires both RAR gamma 2 and RAR alpha 1, and in all cases AF-1 and AF-2 must synergize; (ii) primitive endodermal differentiation requires the proline-directed kinase site of RAR gamma 2-AF-1, whereas parietal endodermal differentiation additionally requires that of RAR alpha 1-AF-1; (iii) the cAMP-induced parietal endodermal differentiation also requires the protein kinase A site of RAR alpha-AF-2, but not that of RAR gamma; and (iv) the AF-1-AF-2 synergism and AF-1 phosphorylation site requirements for RA-responsive gene induction are promoter context-dependent. Thus, AF-1 and AF-2 of distinct RARs exert specific cellular and molecular functions in a cell-autonomous system mimicking physiological situations, and their phosphorylation by kinases belonging to two main signalling pathways is required to enable RARs to transduce the RA signal during F9 cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351827      PMCID: PMC1170251          DOI: 10.1093/emboj/16.21.6452

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

Review 2.  Steroid hormone receptors and their regulation by phosphorylation.

Authors:  N L Weigel
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 3.  Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?

Authors:  P Kastner; M Mark; P Chambon
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

4.  Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7.

Authors:  C Rochette-Egly; S Adam; M Rossignol; J M Egly; P Chambon
Journal:  Cell       Date:  1997-07-11       Impact factor: 41.582

5.  Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells.

Authors:  H Chiba; J Clifford; D Metzger; P Chambon
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

6.  RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids.

Authors:  J Clifford; H Chiba; D Sobieszczuk; D Metzger; P Chambon
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

7.  Role of the retinoic acid receptor beta (RARbeta) during mouse development.

Authors:  N B Ghyselinck; V Dupé; A Dierich; N Messaddeq; J M Garnier; C Rochette-Egly; P Chambon; M Mark
Journal:  Int J Dev Biol       Date:  1997-06       Impact factor: 2.203

8.  Two distinct actions of retinoid-receptor ligands.

Authors:  J Y Chen; J Clifford; C Zusi; J Starrett; D Tortolani; J Ostrowski; P R Reczek; P Chambon; H Gronemeyer
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

9.  Two novel RXR alpha isoforms from mouse testis.

Authors:  J Brocard; P Kastner; P Chambon
Journal:  Biochem Biophys Res Commun       Date:  1996-12-04       Impact factor: 3.575

10.  Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development.

Authors:  P Kastner; M Mark; N Ghyselinck; W Krezel; V Dupé; J M Grondona; P Chambon
Journal:  Development       Date:  1997-01       Impact factor: 6.868

View more
  22 in total

Review 1.  Modulating nuclear receptor function: may the phos be with you.

Authors:  D Shao; M A Lazar
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

2.  Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation.

Authors:  Maurizio Giannì; Annie Bauer; Enrico Garattini; Pierre Chambon; Cécile Rochette-Egly
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

3.  Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms.

Authors:  A Parrado; G Despouy; R Kraïba; C Le Pogam; S Dupas; M Choquette; M Robledo; J Larghero; H Bui; I Le Gall; C Rochette-Egly; C Chomienne; R A Padua
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

4.  Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid.

Authors:  R Mira-Y-Lopez; S Jaramillo; Y Jing
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

5.  Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation.

Authors:  Koren K Mann; Alessandra M S Padovani; Qi Guo; April L Colosimo; Ho-Young Lee; Jonathan M Kurie; Wilson H Miller
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

6.  Activity of retinoic acid receptor-alpha is directly regulated at its protein kinase A sites in response to follicle-stimulating hormone signaling.

Authors:  Nadine C Santos; Kwan Hee Kim
Journal:  Endocrinology       Date:  2010-03-09       Impact factor: 4.736

7.  A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters.

Authors:  Nathalie Bruck; Dominique Vitoux; Christine Ferry; Vanessa Duong; Annie Bauer; Hughes de Thé; Cécile Rochette-Egly
Journal:  EMBO J       Date:  2008-12-11       Impact factor: 11.598

8.  Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL.

Authors:  Nicole Clarke; Ana M Jimenez-Lara; Emilie Voltz; Hinrich Gronemeyer
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

Review 9.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

10.  Transcriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cells.

Authors:  Juliana Xu; Renia Sylvester; Ann P Tighe; Siming Chen; Lorraine J Gudas
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.